Back to DE D. E. Shaw & Co., Inc.

ANIKANIK
Showing 8 of 31 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in ANIKA THERAPEUTICS INC

Yes. D. E. Shaw holds 245,066 shares of ANIK (Anika Therapeutics), worth $3.6M, as of its Q2 2026 13F filing. It increased the position by 15,270 shares (+6.7%) from Q1 2026. D. E. Shaw has held ANIK in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$3.6M

Current Shares

245,066

Total Value Change

-$219,991

Total Shares Change

+91,005

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
245,066
+6.7%
$3.6M0.0%$14.63
28
2026-Q1
Decreased
229,796
-22.9%
$3.3M0.0%$14.50
0
2025-Q4
Increased
297,979
+70.0%
$2.9M0.0%$9.61
39
2025-Q3
Increased
175,315
+41.3%
$1.6M0.0%$9.40
34
2025-Q2
Decreased
124,079
-26.0%
$1.3M0.0%$10.58
0
2025-Q1
Increased
167,760
+9.1%
$2.5M0.0%$15.03
29
2024-Q4
Decreased
153,764
-0.2%
$2.5M0.0%$16.46
0
2024-Q3
Increased
154,061
+0.7%
$3.8M0.0%$24.70
27

Other major holders of ANIK: KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used